Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company
focusing on creating value for people living with
neurology and immunology conditions.
Twitter Feed
-
We’re returning home from #EULAR2018 feeling inspired to keep the momentum going for underserved patients and already looking forward to next year. See you in Madrid! https://t.co/xRGbsRGhD8
— UCB News (@ucb_news) 19.06.2018 -
Succeeding together: UCB joins patients and experts to improve the lives of people with epilepsy https://t.co/kwmtLkEgcj https://t.co/i3QFp2NI4p
— UCB News (@ucb_news) 19.06.2018 -
UCB is continuously working to advance #science and embrace new knowledge. True or False? ⬇️ ⬇️ ✅ True. Already in 1950s UCB set up its own #research center.
— UCB News (@ucb_news) 18.06.2018